196 related articles for article (PubMed ID: 21398304)
1. Antibiotic dosing in critical illness.
McKenzie C
J Antimicrob Chemother; 2011 Apr; 66 Suppl 2():ii25-31. PubMed ID: 21398304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
3. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
[TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
5. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
Klutman NE
Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
[TBL] [Abstract][Full Text] [Related]
7. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
9. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory].
Takesue Y; Nakajima K; Wada Y; Ichiki K; Yanagi H; Ikeuchi H
Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):224-9. PubMed ID: 17017418
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic dosing in slow extended daily dialysis.
Mushatt DM; Mihm LB; Dreisbach AW; Simon EE
Clin Infect Dis; 2009 Aug; 49(3):433-7. PubMed ID: 19580416
[TBL] [Abstract][Full Text] [Related]
14. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
Reed MD
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
[TBL] [Abstract][Full Text] [Related]
16. Single daily dose and simplified dosing regimens as a method to improve antibiotic therapy.
McDaniel A
Pharm Pract Manag Q; 1996 Jul; 16(2):57-61. PubMed ID: 10161613
[TBL] [Abstract][Full Text] [Related]
17. Principles of antibacterial dosing in continuous renal replacement therapy.
Choi G; Gomersall CD; Tian Q; Joynt GM; Li AM; Lipman J
Blood Purif; 2010; 30(3):195-212. PubMed ID: 20924175
[TBL] [Abstract][Full Text] [Related]
18. Once-daily versus multiple-daily dosing of aminoglycosides.
Craig WA
J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
[TBL] [Abstract][Full Text] [Related]
19. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
Jamal JA; Economou CJ; Lipman J; Roberts JA
Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
[TBL] [Abstract][Full Text] [Related]
20. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
Mueller EW; Boucher BA
Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
